Presentation TCT 2024 TCT 1012: Pre-Emptive PCI in Vulnerable Coronary Plaques Reduces Biomechanical and Anatomic High-Risk Features: The PROSPECT ABSORB Trial Presenter: Diaa Hakim October 29, 2024
Presentation TCT 2024 TCT 368: Coronary Physiology After Drug-Eluting Absorbable Metallic Scaffold Presenter: Ryan Wallace October 29, 2024
Presentation TCT 2024 TCT 360: Mechanisms of Lumen Reduction After Implantation of a Drug-Eluting Absorbable Metal Scaffold Presenter: Kirstine Hansen October 27, 2024
Presentation TCT 2022 TCT 60: The impact of implantation techniques in Absorb BVS and Xience EES on lesion oriented-outcomes at complete five-year follow-up – an AIDA trial QCA substudy Presenter: Mick Renkens September 17, 2022
Presentation TCT 2022 TCT 52: Structural and Functional Evaluation of Coronary Arteries Treated With Absorb Bioresorbable Vascular Scaffold at 5-Year Follow-Up Presenter: Luis Goncalves-Ramírez September 17, 2022
News Conference News TCT 2021 Good Long-term Results With FANTOM BVS, but More Data Needed Michael O'Riordan October 21, 2021
News Conference News TCT 2020 OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES L.A. McKeown October 17, 2020
Presentation TCT 2020 The PROSPECT ABSORB Trial: Randomized Evaluation of Vulnerable Plaque Treatment with Percutaneous Coronary Intervention Presenter: Gregg Stone October 14, 2020
News Conference News TCT 2020 Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB Michael O'Riordan October 14, 2020
News Conference News TCT 2019 Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE Michael O'Riordan September 30, 2019
Presentation TCT 2019 The Post-Absorb BVS Era: Lessons Learned and Implications for Trial Design and Device Approval Presenter: Andrew Farb September 28, 2019
Presentation TCT 2019 The Absorb BVS Epilogue: How Did We Miss the Safety Signals? Presenter: Renu Virmani September 28, 2019
Presentation TCT 2019 TCT 7: Blinded Outcomes Assessment of Absorb Bioresorbable Scaffolds Implanted With Improved Technique: Two-year Results From the ABSORB IV Randomized Trial Presenter: Gregg Stone September 28, 2019
Presentation TCT 2019 ABSORB 5-Year Pooled Analysis: Improving Very Late Outcomes of the Absorb Bioresorbable Scaffold in Coronary Artery Disease From 4 Randomized Trials Presenter: Gregg Stone September 27, 2019
Presentation TCT 2019 Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update Presenter: David Erlinge September 27, 2019
Presentation TCT 2019 TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT Presenter: Robert-Jan Van Geuns September 25, 2019
Presentation TCT 2019 TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial Presenter: Run-Lin Gao September 25, 2019
Presentation TCT 2019 TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial Presenter: Jens Wiebe September 25, 2019
News Opinion Off Script TCT 2018 Off Script: Phantom Hearts and the Elusive Nature of Angina Kwan S. Lee October 11, 2018
News Conference News TCT 2018 Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials Michael O'Riordan September 25, 2018